» Articles » PMID: 38238979

RETRACTED: Safety of Radiofrequency Ablation for Reducing Inflammatory Cytokine Levels and the Left Atrial Diameter in Patients with Atrial Fibrillation

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2024 Jan 19
PMID 38238979
Authors
Affiliations
Soon will be listed here.
References
1.
Nagashima K, Okumura Y, Watanabe I, Nakahara S, Hori Y, Iso K . Hot Balloon Versus Cryoballoon Ablation for Atrial Fibrillation: Lesion Characteristics and Middle-Term Outcomes. Circ Arrhythm Electrophysiol. 2018; 11(5):e005861. DOI: 10.1161/CIRCEP.117.005861. View

2.
Talman V, Ruskoaho H . Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res. 2016; 365(3):563-81. PMC: 5010608. DOI: 10.1007/s00441-016-2431-9. View

3.
Olbers J, Jacobson E, Viberg F, Witt N, Ljungman P, Rosenqvist M . Systolic blood pressure increases in patients with atrial fibrillation regaining sinus rhythm after electrical cardioversion. J Clin Hypertens (Greenwich). 2019; 21(3):363-368. PMC: 8030486. DOI: 10.1111/jch.13496. View

4.
Morillo C, Verma A, Connolly S, Kuck K, Nair G, Champagne J . Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014; 311(7):692-700. DOI: 10.1001/jama.2014.467. View

5.
Kaba R, Cannie D, Ahmed O . RAAFT-2: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation. Glob Cardiol Sci Pract. 2014; 2014(2):53-5. PMC: 4220435. DOI: 10.5339/gcsp.2014.26. View